Imugene (ASX:IMU)
ASX announcement history & article coverage
Transparent by design.
Announcments by Imugene (ASX:IMU) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Cleansing Notice
Application for quotation of securities - IMU
Application for quotation of securities - IMU
Notification of cessation of securities - IMU
Change of Director's Interest Notice x5
Imugene Capital Raising Presentation
Proposed issue of securities - IMU
$11.1 Million Placement Completed to Advance azer-cel
Imugene raises $11.1 million placement to advance azer-cel after positive clinical data
Initial Director's Interest Notice - CG & MK
Trading Halt
New Complete Response in the Concurrent BTKi azer-cel Cohort
Imugene reports additional complete response in Phase 1b azer-cel BTKi cohort including first MCL patient
First Complete Response in Concurrent BTKi azer-cel Cohort
Imugene Reports First Complete Response in BTKi Cohort of Phase 1b Azer-cel Trial
Azer-cel Granted FDA Fast Track Designation for CLL and MZL
Imugene's Azer-cel Granted FDA Fast Track Designation for CLL/SLL and MZL
Notification regarding unquoted securities - IMU
azer-cel CAR-T naive data presented at ASCO Annual Meeting
First Patient in BTKi Combination Cohort of azer-cel study
Imugene doses first patient in BTKi combination cohort of azer-cel Phase 1b trial targeting BTKi-relapsed B-cell malignancies
Appointment of 2 non-Executive Directors
Azer-cel Data from CAR T naive cohort in ASCO 2026 abstract
Imugene’s Azer-cel Shows 81% Response Rate in CAR T-Naïve Blood Cancer Patients at ASCO 2026
Change of Director's Interest Notice - PH
Change of Director's Interest Notice - LC
Ceasing to be a substantial holder
Application for quotation of securities - IMU
Notice under section 708A(12C)(e) of the Corporations Act
Notification regarding unquoted securities - IMU
Notification of cessation of securities - IMU
Application for quotation of securities - IMU
Proposed issue of securities - IMU
Application for quotation of securities - IMU
Quarterly Activities/Appendix 4C Cash Flow Report
Imugene reports positive azer-cel trial results, $16M capital raise, and ASCO 2026 oral presentation
Listed Options Top Holders & Holdings Range Report
Application for quotation of securities - IMU
Application for quotation of securities - IMU
EGM Results and Share Purchase Plan Final Allotment
Change of Director's Interest Notice -LC